Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome

The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders

Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458 · see citing works

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143 · see citing works

Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976 · see citing works

Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline

Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919 · see citing works

The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited

Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603 · see citing works

Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome

Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020 · see citing works

Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences

Anagnostis, P. G., Tarlatzis, B. C., & Kauffman, R. P. (2017) · Metabolism · doi:10.1016/j.metabol.2017.09.016 · Cited by 428 · see citing works

Molecular mechanisms of insulin resistance in polycystic ovary syndrome

Diamanti-Kandarakis, E., & Papavassiliou, A. G. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.05.006 · Cited by 301 · see citing works

Pathophysiology and types of dyslipidemia in PCOS

Diamanti‐Kandarakis, E., Papavassiliou, A. G., Kandarakis, S., & Chrousos, G. P. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.07.004 · Cited by 301 · see citing works

Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling

Corbould, A., Kim, Y.-B., Youngren, J. F., Pender, C., Kahn, B. B., Lee, A., & Dunaif, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2004 · Cited by 283 · see citing works

Metabolic risk in PCOS: Phenotype and adiposity impact

Moran, L. J., Norman, R. J., & Teede, H. J. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.12.003 · Cited by 245 · see citing works

Functional genomics of PCOS: from GWAS to molecular mechanisms

McAllister, J. M., Legro, R. S., Modi, B. P., & Strauss, J. F. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.12.004 · Cited by 220 · see citing works

The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase.

Endoh, A., Kristiansen, S. B., Casson, P. R., Buster, J. E., & Hornsby, P. J. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855801 · Cited by 219 · see citing works

Polycystic Ovary Syndrome

Meier, R. K. (2018) · Nursing Clinics of North America · doi:10.1016/j.cnur.2018.04.008 · Cited by 208 · see citing works

Brown adipose tissue transplantation ameliorates polycystic ovary syndrome

Yuan, X., Hu, T., Zhao, H., Huang, Y., Ye, R., Lin, J., Zhang, C., Zhang, H., Wei, G., Zhou, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523236113 · Cited by 202 · see citing works

Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS)

Li, Y., Chen, C.-Y., Ma, Y., Xiao, J., Luo, G., Li, Y., & Wu, D. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.046 · Cited by 201 · see citing works

Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH

Banimohammad, M., & Seghinsara, A. M. (2017) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2017.18.1.17 · Cited by 193 · see citing works

Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)

Palioura, E., & Diamanti-Kandarakis, E. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9326-7 · Cited by 161 · see citing works

Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS

Dokras, A., Sarwer, D. B., Allison, K. C., Milman, L., Kris-Etherton, P. M., Kunselman, A. R., Stetter, C. M., Williams, N. I., Gnatuk, C. L., Estes, S. J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1896 · Cited by 161 · see citing works

Expression of Adiponectin Receptors and Its Possible Implication in the Human Endometrium

Takemura, Y., Osuga, Y., Yamauchi, T., Kobayashi, M., Harada, M., Hirata, T., Morimoto, C., Hirota, Y., Yoshino, O., Koga, K., et al. (2006) · Endocrinology · doi:10.1210/en.2005-1510 · Cited by 159 · see citing works

Up-Regulated Expression of WNT5a Increases Inflammation and Oxidative Stress via PI3K/AKT/NF-κB Signaling in the Granulosa Cells of PCOS Patients

Zhao, Y., Zhang, C., Huang, Y., Yu, Y., Li, R., Li, M., Liu, N., Liu, P., & Qiao, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2419 · Cited by 154 · see citing works

Is foetal hyperexposure to androgens a cause of PCOS?

Filippou, P., & Homburg, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx013 · Cited by 152 · see citing works

Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS

Irani, M., MINKOFF, H. L., Seifer, D. B., & Merhi, Z. O. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4374 · Cited by 148 · see citing works

Childhood Obesity and Its Impact on the Development of Adolescent PCOS

Anderson, A., Solorzano, C. M. B., & McCartney, C. R. (2014) · Seminars in Reproductive Medicine · doi:10.1055/s-0034-1371092 · Cited by 146 · see citing works

The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?

Wang, R., & Mol, B. W. (2016) · Human Reproduction · doi:10.1093/humrep/dew287 · Cited by 138 · see citing works

Adiponectin protects against development of metabolic disturbances in a PCOS mouse model

Benrick, A., Chanclón, B., Micallef, P., Wu, Y., Hadi, L., Shelton, J. M., Stener‐Victorin, E., & Asterholm, I. W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708854114 · Cited by 138 · see citing works

Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies

Fernandez, R., Moore, V., Van Ryswyk, E., Varcoe, T., Rodgers, R., March, W., Moran, L., Avery, J., McEvoy, D., & Davies, M. (2018) · Nature and Science of Sleep · doi:10.2147/nss.s127475 · Cited by 137 · see citing works

Hyperandrogenic origins of polycystic ovary syndrome-Implications for Pathophysiology and Therapy

Abbott, D. H., Dumesic, D. A., & Levine, J. E. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1576522 · Cited by 131 · see citing works

Genetics of polycystic ovary syndrome

Mykhalchenko, K., Lizneva, D., Trofimova, T., Walker, W., Сутурина, Л. В., Diamond, M. P., & Azziz, R. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1340833 · Cited by 124 · see citing works

Implications and Future Perspectives of AGEs in PCOS Pathophysiology

Merhi, Z. O., Kandaraki, E., & Diamanti‐Kandarakis, E. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.01.005 · Cited by 124 · see citing works

Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women

Schmidt, J., Weijdegård, B., Mikkelsen, A., Lindenberg, S., Nilsson, L., & Brännström, M. (2013) · Molecular Human Reproduction · doi:10.1093/molehr/gat051 · Cited by 123 · see citing works

Psychological Distress Is More Prevalent in Fertile Age and Premenopausal Women With PCOS Symptoms: 15-Year Follow-Up

Karjula, S., Morin-Papunen, L. C., AUVINEN, J. P., Ruokonen, A., Puukka, K. S., Franks, S., Järvelin, M., Tapanainen, J. S., Jokelainen, J. J., Miettunen, J., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3863 · Cited by 122 · see citing works

Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review

Lautatzis, M.-E., Goulis, D. G., & Vrontakis, M. (2013) · Metabolism · doi:10.1016/j.metabol.2013.06.006 · Cited by 113 · see citing works

Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity

Jones, M. R., Brower, M. A., Xu, N., Cui, J., Mengesha, E., Chen, Y. I., Taylor, K. D., Azziz, R., & Goodarzi, M. O. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005455 · Cited by 111 · see citing works

Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols

Laganà, A. S., Rossetti, P., Buscema, M., Vignera, S. L., Condorelli, R. A., Gullo, G., Granese, R., & Triolo, O. (2016) · International Journal of Endocrinology · doi:10.1155/2016/6306410 · Cited by 108 · see citing works

Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome

Kelley, C. E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14172 · Cited by 101 · see citing works

Metformin in Reproductive Biology

Faure, M., Bertoldo, M. J., Khoueiry, R., Bongrani, A., Brion, F., Giulivi, C., Dupont, J., & Froment, P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00675 · Cited by 100 · see citing works

Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials

Facchinetti, F., Orrù, B., Grandi, G., & Unfer, V. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1540578 · Cited by 94 · see citing works

Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome

Sam, S., & Ehrmann, D. A. (2017) · Diabetologia · doi:10.1007/s00125-017-4306-3 · Cited by 93 · see citing works

Cumulative conception rates following gonadotropin therapy

Dor, J., Itzkowic, D. J., Mashiach, S., Lunenfeld, B., & Serr, D. M. (1980) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(80)90574-8 · Cited by 90 · see citing works

Metabolic syndrome enhances endoplasmic reticulum, oxidative stress and leukocyte–endothelium interactions in PCOS

Bañuls, C., Rovira‐Llopis, S., Marañón, A., Veses, S., Jover, A., Gomez, M., Rocha, M., Hernández‐Mijares, A., & Víctor, V. M. (2017) · Metabolism · doi:10.1016/j.metabol.2017.02.012 · Cited by 90 · see citing works

Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome

Wang, M., Zhao, D. Y., Xu, L., Guo, W., Nie, L., Lei, Y., Long, Y., Liu, M., Wang, Y., Zhang, X., et al. (2019) · Metabolism · doi:10.1016/j.metabol.2019.02.002 · Cited by 89 · see citing works

Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters

Siemińśka, L., Marek, B., Kos‐Kudła, B., Niedziolka, D., Kajdaniuk, D., Nowak, M., & Głogowska-Szeląg, J. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347474 · Cited by 85 · see citing works

Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS

Ryan, G. E., Malik, S., & Mellon, P. L. (2018) · Endocrinology · doi:10.1210/en.2017-03218 · Cited by 83 · see citing works

Hirsutism in Polycystic Ovary Syndrome: Pathophysiology and Management

Spritzer, P. M., Barone, C. R., & de OLIVEIRA, F. M. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160720151243 · Cited by 82 · see citing works

Metformin in Pregnancy: Mechanisms and Clinical Applications

Hyer, S. L., Balani, J., & Shehata, H. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071954 · Cited by 80 · see citing works

Dehydroepiandrosterone 7α-hydroxylation in human tissues: Possible interference with type 1 11β-hydroxysteroid dehydrogenase-mediated processes

Hennebert, O., Chalbot, S., Alran, S., & Morfin, R. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.03.026 · Cited by 79 · see citing works

Vitamin D Deficiency Is Associated With Poor Ovarian Stimulation Outcome in PCOS but Not Unexplained Infertility

Butts, S. F., Seifer, D. B., Koelper, N., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00750 · Cited by 75 · see citing works

Decreased Cholesterol Efflux Capacity and Atherogenic Lipid Profile in Young Women With PCOS

Roe, A. H., Hillman, J., Butts, S. F., Smith, M. P., Rader, D. J., Playford, M. P., Mehta, N. N., & Dokras, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3918 · Cited by 69 · see citing works

Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake

McNelis, J., Manolopoulos, K. N., Gathercole, L., Bujalska, I. J., Stewart, P. M., Tomlinson, J., & Arlt, W. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00314.2012 · Cited by 66 · see citing works

MicroRNAs related to androgen metabolism and polycystic ovary syndrome

Sørensen, A. E., Udesen, P. B., Wissing, M. L., Englund, A. L. M., & Dalgaard, L. T. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.06.008 · Cited by 65 · see citing works

Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery

Seow, K., Juan, C., Hsu, Y.-P., Hwang, J., Huang, L., & Ho, L. (2007) · Human Reproduction · doi:10.1093/humrep/del466 · Cited by 64 · see citing works

Altered aquaporin expression in women with polycystic ovary syndrome: hyperandrogenism in follicular fluid inhibits aquaporin-9 in granulosa cells through the phosphatidylinositol 3-kinase pathway

Qu, F., Wang, F., Lu, X.-P., Dong, M. Y., Sheng, J., Lv, P. P., Ding, G., Shi, B., Zhang, D., & Huang, H. (2010) · Human Reproduction · doi:10.1093/humrep/deq078 · Cited by 64 · see citing works

History of discovery of polycystic ovary syndrome

Szydlarska, D., Machaj, M., & Jakimiuk, A. J. (2017) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/61987 · Cited by 63 · see citing works

Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial

Shokrpour, M., Foroozanfard, F., Afshar Ebrahimi, F., Vahedpoor, Z., Aghadavod, E., Ghaderi, A., & Asemi, Z. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1540570 · Cited by 63 · see citing works

Prenatal Exposure to Endocrine Disruptors: A Developmental Etiology for Polycystic Ovary Syndrome

Hewlett, M., Chow, E., Aschengrau, A., & Mahalingaiah, S. (2017) · Reproductive Sciences · doi:10.1177/1933719116654992 · Cited by 61 · see citing works

The Hormonal Phenotype of Nonclassic 3β-Hydroxysteroid Dehydrogenase (HSD3B) Deficiency in Hyperandrogenic Females Is Associated with Insulin-Resistant Polycystic Ovary Syndrome and Is Not a Variant of Inherited HSD3B2 Deficiency

Carbunaru, G., Prasad, P., Scoccia, B., Shea, P., Hopwood, N. J., Ziai, F., Chang, Y., Myers, S. E., Mason, J. I., & Pang, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030934 · Cited by 60 · see citing works

Association of Luteinizing Hormone Chorionic Gonadotropin Receptor Gene Polymorphism (rs2293275) with Polycystic Ovarian Syndrome

Thathapudi, S., Kodati, V., Erukkambattu, J., Addepally, U., & Qurratulain, H. (2015) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2014.0249 · Cited by 58 · see citing works

New guidelines for the diagnosis and treatment of PCOS

Orio, F., & Palomba, S. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.248 · Cited by 57 · see citing works

The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy

Spinedi, E., & Cardinali, D. P. (2018) · International Journal of Endocrinology · doi:10.1155/2018/1349868 · Cited by 52 · see citing works

Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome

Lerchbaum, E., Theiler‐Schwetz, V., Giuliani, A., Pieber, T. R., & Obermayer-Pietsch, B. M. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.07.1057 · Cited by 51 · see citing works

The post-translational regulation of 17,20 lyase activity

Miller, W. L., & Tee, M. K. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.010 · Cited by 51 · see citing works

Long-Term Effects of Oral Antidiabetic Drugs During Pregnancy on Offspring: A Systematic Review and Meta-analysis of Follow-up Studies of RCTs

van Weelden, W., Wekker, V., de Wit, L., Limpens, J., Nikkinen, H., Leemhuis, A. G., Roseboom, T. J., van Rijn, B. B., DeVries, J. H., & Painter, R. C. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0479-0 · Cited by 50 · see citing works

Evidence for Decreased Expression of ADAMTS-1 Associated With Impaired Oocyte Quality in PCOS Patients

Xiao, S., Li, Y., Li, T., Chen, M., Xu, Y., Wen, Y., & Zhou, C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4177 · Cited by 47 · see citing works

Inositol Treatment and ART Outcomes in Women with PCOS

Garg, D., & Tal, R. (2016) · International Journal of Endocrinology · doi:10.1155/2016/1979654 · Cited by 47 · see citing works

A pilot trial of metformin for insulin resistance and mood disturbances in adolescent and adult women with polycystic ovary syndrome

Erensoy, H., Niafar, M., Rad, S. G., Aghamohammadzadeh, N., & Nader, N. D. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1498476 · Cited by 47 · see citing works

Urinary steroid profiling in women hints at a diagnostic signature of the polycystic ovary syndrome: A pilot study considering neglected steroid metabolites

Dhayat, N. A., Marti, N., Kollmann, Z., Troendle, A., Bally, L., Escher, G., Groessl, M., Ackermann, D., Ponte, B., Pruijm, M. T., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203903 · Cited by 46 · see citing works

A common polymorphism in the human aromatase gene alters the risk for polycystic ovary syndrome and modifies aromatase activity in vitro

Wang, H., Li, Q., Wang, T., Gui-zhong, Y., Wang, Y., Zhang, X., Sang, Q., Wang, H., Zhao, X., Xing, Q., et al. (2011) · Molecular Human Reproduction · doi:10.1093/molehr/gar007 · Cited by 44 · see citing works

Association of rs10830963 and rs10830962 SNPs in the melatonin receptor (MTNR1B) gene among Han Chinese women with polycystic ovary syndrome

Li, C., Shi, Y., You, L., et al. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq087 · Cited by 43 · see citing works

Downregulation of adiponectin system in granulosa cells and low levels of HMW adiponectin in PCOS

Artimani, T., Saidijam, M., Aflatoonian, R., Ashrafi, M., Amiri, I., Yavangi, M., Asl, S. S., Shabab, N., Karimi, J., & Mehdizadeh, M. (2015) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-015-0620-1 · Cited by 42 · see citing works

Abnormal infant islet morphology precedes insulin resistance in PCOS-like monkeys

Nicol, L. E., O’Brien, T. D., Dumesic, D. A., Grogan, T., Tarantal, A. F., & Abbott, D. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106527 · Cited by 41 · see citing works

Polymorphism of the follistatin gene in polycystic ovary syndrome

Jones, M. R., Wilson, S. G., Mullin, B. H., Mead, R., Watts, G. F., & Stuckey, B. G. A. (2007) · Molecular Human Reproduction · doi:10.1093/molehr/gal120 · Cited by 41 · see citing works

Adrenal Hyperandrogenism and Polycystic Ovary Syndrome

Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160720150625 · Cited by 41 · see citing works

Altered Steroid Metabolism and Insulin Signaling in PCOS Endometria: Impact in Tissue Function

Oróstica, L., Rosas, C., Plaza-Parrochia, F., Astorga, I., Gabler, F., García, V., Romero, C., & Vega, M. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160810111528 · Cited by 40 · see citing works

Developmental Programming by Androgen Affects the Circadian Timing System in Female Mice1

Mereness, A. L., Murphy, Z. C., & Sellix, M. T. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.114.126409 · Cited by 39 · see citing works

Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment

Tao, T., Wu, P., Wang, Y., & Liu, W. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0243-5 · Cited by 38 · see citing works

LINE1 CpG-DNA Hypomethylation in Granulosa Cells and Blood Leukocytes Is Associated With PCOS and Related Traits

Sagvekar, P., Mangoli, V. S., Desai, S. K., Patil, A. D., & Mukherjee, S. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2645 · Cited by 37 · see citing works

Increased Androgen, Anti-Müllerian Hormone, and Sporadic Anovulation in Healthy, Eumenorrheic Women: A Mild PCOS-Like Phenotype?

Sjaarda, L. A., Mumford, S. L., Kissell, K., Schliep, K. C., Hammoud, A. O., Perkins, N. J., Weck, J., Wactawski‐Wende, J., & Schisterman, E. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3781 · Cited by 34 · see citing works

Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage

Chua, A. K., Azziz, R., & Goodarzi, M. O. (2012) · Molecular Human Reproduction · doi:10.1093/molehr/gas002 · Cited by 32 · see citing works

Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis

Wang, R., Goodarzi, M. O., Xiong, T., Wang, D., Azziz, R., & Zhang, H. (2012) · Molecular Human Reproduction · doi:10.1093/molehr/gas024 · Cited by 31 · see citing works

High insulin impaired ovarian function in early pregnant mice and the role of autophagy in this process

Su, Y., Wu, J., He, J., Liu, X., Chen, X., Ding, Y., Zhang, C., Chen, W., Wang, Y., & Gao, R. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej16-0494 · Cited by 30 · see citing works

Effects of hypoxia‑inducible factor‑1α on endometrial receptivity of women with polycystic ovary syndrome

Zhao, D., Qu, Q., Dai, H., Liu, Y., Jiang, L., Huang, X. Y., & Hao, C. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7890 · Cited by 29 · see citing works

Elevation of antimüllerian hormone in women with polycystic ovary syndrome undergoing assisted reproduction: effect of insulin

Liu, X., Yang, Y. J., Tang, C. L., Wang, K., Chen, J.-J., Teng, X., Ruan, Y. C., & Yang, J. Z. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.09.022 · Cited by 29 · see citing works

Endometria from Obese PCOS Women with Hyperinsulinemia Exhibit Altered Adiponectin Signaling

García, V., Oróstica, L., Poblete, C., et al. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1555806 · Cited by 28 · see citing works

Long-term exposure to dehydroepiandrosterone affects the transcriptional activity of the glucocorticoid receptor

Saponaro, S., Guarnieri, V., Pescarmona, G., & Silvagno, F. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.08.003 · Cited by 28 · see citing works

The Emerging Roles of Adiponectin in Female Reproductive System-Associated Disorders and Pregnancy

Angelidis, G., Dafopoulos, K. C., Messini, C. I., Valotassiou, V. J., Tsikouras, P. N., Vrachnis, N., Psimadas, D., Georgoulias, P., & Messinis, I. E. (2012) · Reproductive Sciences · doi:10.1177/1933719112468954 · Cited by 28 · see citing works

Effect of exposure to second-hand smoke from husbands on biochemical hyperandrogenism, metabolic syndrome and conception rates in women with polycystic ovary syndrome undergoing ovulation induction

Li, J., Wu, Q., Wu, X.-K., Zhou, Z.-M., Fu, P., Chen, X.-H., Yan, Y., Wang, X., Yang, Z.-W., Li, W.-L., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey027 · Cited by 28 · see citing works

Pregnancy outcome after first-trimester exposure to metformin: A prospective cohort study

Scherneck, S., Schlinke, N. F., Beck, E., Grupe, K., Weber‐Schoendorfer, C., & Schaefer, C. (2018) · Reproductive Toxicology · doi:10.1016/j.reprotox.2018.07.004 · Cited by 28 · see citing works

Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome

Loverro, G., Lorusso, F., De Pergola, G., Nicolardi, V., Mei, L., & Selvaggi, L. (2002) · Gynecological Endocrinology · doi:10.1080/713603060 · Cited by 27 · see citing works

Variants in SULT2A1 Affect the DHEA Sulphate to DHEA Ratio in Patients With Polycystic Ovary Syndrome But Not the Hyperandrogenic Phenotype

Louwers, Y. V., de Jong, F. H., van Herwaarden, N. A. A., Stolk, L., Fauser, B. C. J. M., Uitterlinden, A. G., & Laven, J. S. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1976 · Cited by 26 · see citing works

Genetic Variation in the 11β-hydroxysteroid-dehydrogenase 1 Gene Determines NAFLD and Visceral Obesity

Lutz, S. Z., Peter, A., Machicao, F. E., Lamprinou, A., Machann, J., Schick, F., Königsrainer, I., Königsrainer, A., Fritsche, A., Staiger, H., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2498 · Cited by 26 · see citing works

[Effect of electroacupuncture on oocyte quality and pregnancy for patients with PCOS undergoing in vitro fertilization and embryo transfervitro fertilization and embryo transfer].

Cui, W., Li, J., Sun, W. C., et al. (2011) · PubMed · Cited by 24 · see citing works

PDE8A genetic variation, polycystic ovary syndrome and androgen levels in women

Chen, C., Wickenheisser, J. K., Ewens, K. G., Ankener, W., Legro, R. S., Dunaif, A. E., McAllister, J. M., Spielman, R. S., & Strauss, J. F. (2009) · Molecular Human Reproduction · doi:10.1093/molehr/gap035 · Cited by 24 · see citing works

Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews

Tay, C. T., Joham, A. E., Hiam, D., Gadalla, M. A., Pundir, J., Thangaratinam, S., Teede, H. J., & Moran, L. (2018) · Clinical Endocrinology · doi:10.1111/cen.13753 · Cited by 23 · see citing works

Serum visfatin and adiponectin – markers in women with polycystic ovarian syndrome

Bannigida, D. M., Nayak, S. B., & Vijayaragavan, R. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1518987 · Cited by 23 · see citing works

Acupuncture or metformin to improve insulin resistance in women with polycystic ovary syndrome: study protocol of a combined multinational cross sectional case-control study and a randomised controlled trial

Stener‐Victorin, E., Zhang, H., Li, R., Fridén, C., Li, D., Wang, W., Wang, H., Chang, C., Shi, L., Huo, Z., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024733 · Cited by 23 · see citing works

Metabolic disorders in polycystic ovary syndrome

Wikiera, B., Zubkiewicz‐Kucharska, A., Nocoń-Bohusz, J., & Noczyńska, A. (2017) · Pediatric Endocrinology Diabetes and Metabolism · doi:10.18544/pedm-23.04.0094 · Cited by 20 · see citing works

Does Metformin Treatment During Pregnancy Modify the Future Metabolic Profile in Women With PCOS?

Underdal, M. O., Stridsklev, S., Oppen, I. H., Høgetveit, K., Andersen, M., & Vanky, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00485 · Cited by 19 · see citing works

Effects of Testosterone on Renal Function in Salt-Loaded Rats

Hu, J., Tan, S., & Zhong, Y. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31820f835b · Cited by 18 · see citing works

Influence of Sleep Stage on LH Pulse Initiation in the Normal Late Follicular Phase and in Polycystic Ovary Syndrome

Lu, C. Y., Hutchens, E. G., Farhy, L. S., Bonner, H., Suratt, P. M., & McCartney, C. R. (2018) · Neuroendocrinology · doi:10.1159/000488110 · Cited by 16 · see citing works

Insulin Sensitizers Modulate GnRH Receptor Expression in PCOS Rats

Patel, R., & Shah, G. B. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.08.001 · Cited by 16 · see citing works

Effectiveness and safety of metformin versus Canthex™ in patients with acanthosis nigricans: A randomized, double-blind controlled trial

Das, N., Sett, A., Pradhan, S., Sancheti, K., Basu, D., Datta, A., Biswas, L., Das, S., Pal, S., Gupta, N., et al. (2019) · Indian Journal of Dermatology · doi:10.4103/ijd.ijd_417_17 · Cited by 16 · see citing works

Polycystic ovary syndrome and metabolic syndrome: the worrisome twosome?

Shah, D., & Rasool, S. (2015) · Climacteric · doi:10.3109/13697137.2015.1116505 · Cited by 13 · see citing works

Genetic variations in the 3′-untranslated region ofSLC18A2are associated with serum FSH concentration in polycystic ovary syndrome patients and regulate gene expressionin vitro

Li, Q., Yan, Z., Kuang, Y., Zhou, X., Li, J., He, L., Sun, X., Tao, T., & Wang, L. (2016) · Human Reproduction · doi:10.1093/humrep/dew162 · Cited by 13 · see citing works

Developmental origins of polycystic ovary syndrome (PCOS), a case control study comparing birth weight in women with PCOS and control group

Sadrzadeh, S., Painter, R. C., & Lambalk, C. B. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1186632 · Cited by 12 · see citing works

Bisphenol S increases EZRIN expression and the detrimental effects induced by dehydroepiandrosterone in rat endometrium

Demacopulo, B., & Kreimann, E. L. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.01.006 · Cited by 12 · see citing works

Methylprednisolone for prevention of ovarian hyperstimulation syndrome in patients with polycystic ovarian syndrome undergoing in-vitro fertilisation: a randomised controlled trial

Yeganeh, L. M., Moini, A., Shiva, M., et al. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2017.1346593 · Cited by 11 · see citing works

In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: A prospective comparative observational study

Diav‐Citrin, O., Steinmetz-Shoob, S., Shechtman, S., & Ornoy, A. (2018) · Reproductive Toxicology · doi:10.1016/j.reprotox.2018.05.007 · Cited by 11 · see citing works

Metformin and Pregnancy Outcomes: Evidence Gaps and Unanswered Questions

González, C. D., Alvariñas, J., Bagnes, M. F. G., & Girolamo, G. D. (2018) · Current Clinical Pharmacology · doi:10.2174/1574884714666181224151116 · Cited by 9 · see citing works

Maternal and fetal insulin levels at birth in women with polycystic ovary syndrome: data from a randomized controlled study on metformin

Helseth, R., Vanky, E., Stridsklev, S., Vogt, C. M., & Carlsen, S. M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0859 · Cited by 8 · see citing works

A potential determinant role of adiponectin and receptors for the early embryo development in PCOS patients with obesity hinted by quantitative profiling

Zhang, N., Hao, C., Liu, X., Zhang, S., Zhang, F., Zhuang, L., & Zhao, D. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1214259 · Cited by 7 · see citing works

Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes

Hafez, M. M., Musa, N., Elbehairy, S., Sharaf, S. A. E.-A., Elbarbary, M., & Amin, M. M. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0430 · Cited by 7 · see citing works

[Electroacupuncture Combined with Clomiphene Promotes Pregnancy and Blastocyst Implantation Possibly by Up-regulating Expression of Insulin Receptor and Insulin Receptor Substrate 1 Proteins in Endometrium in Rats with PCOS].

Lai, M.-H., Ma, H., & Song, X. (2016) · PubMed · Cited by 4 · see citing works

Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing

Sadeghi, H. M., Adeli, I., Calina, D., Docea, A. O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A., & Abdollahi, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020583 · Cited by 445 · see citing works

Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment

Zhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-022-01091-0 · Cited by 408 · see citing works

Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: A review

He, F.-F., & Li, Y.-M. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00670-3 · Cited by 289 · see citing works

The Role of Lifestyle Interventions in PCOS Management: A Systematic Review

Gautam, R., Maan, P., Jyoti, A., Kumar, A., Malhotra, N., & Arora, T. (2025) · Nutrients · doi:10.3390/nu17020310 · Cited by 115 · see citing works

Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment

parker, J., O'Brien, C., Hawrelak, J., & Gersh, F. (2021) · doi:10.20944/preprints202112.0088.v1 · Cited by 113 · see citing works

Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment

Parker, J., O’Brien, C., Hawrelak, J., & Gersh, F. L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031336 · Cited by 114 · see citing works

Circulating Adipokine Levels in Nonobese Women with Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis

Lin, K., Sun, X., Wang, X., Wang, H., & Chen, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.537809 · Cited by 81 · see citing works

Mediterranean Diet Combined With a Low-Carbohydrate Dietary Pattern in the Treatment of Overweight Polycystic Ovary Syndrome Patients

Mei, S., Ding, J., Wang, K., Ni, Z., & Yu, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.876620 · Cited by 75 · see citing works

Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance

Herman, R., Sikonja, J., Jensterle, M., Janez, A., & Dolzan, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043140 · Cited by 69 · see citing works

Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross—Sectional study

Hasan, M., Sultana, S., Sohan, M., Parvin, S., Rahman, M. A., Hossain, M. J., Rahman, M. S., & Islam, M. R. (2022) · PLOS ONE · doi:10.1371/journal.pone.0270102 · Cited by 45 · see citing works

High-Fiber Diet or Combined With Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota

Wang, X., Xu, T., Liu, R., Wu, G., Gu, L., Zhang, Y., Zhang, F., Fu, H., Ling, Y., Wei, X., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.806331 · Cited by 42 · see citing works

Investigation of common risk factors between polycystic ovary syndrome and Alzheimer’s disease: a narrative review

Sarahian, N., Sarvazad, H., Sajadi, E., Rahnejat, N., & Eskandari Roozbahani, N. (2021) · Reproductive Health · doi:10.1186/s12978-021-01203-x · Cited by 30 · see citing works

Prevalence and pattern of diabetic dyslipidemia in Indian type 2 diabetic patients

Parikh, R. M., Joshi, S., Menon, P. S. N., & Shah, N. S. (2009) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2009.04.005 · Cited by 42 · see citing works

Insulin resistance 'and polycystic ovary syndrome (PCOS) ': Part 1. The impact of insulin resistance

McEwen, B. J., & Hartmann, G. (2018) · Journal of the Australian Traditional-Medicine Society · Cited by 2 · see citing works

Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome?

Di, N., Zhou, X., Chen, Y., Zhao, X., Li, L., Jiang, L., Luo, B., Chen, X., & Yang, D. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000119 · Cited by 2 · see citing works

The relationship between epicardial fat thickness and insulin resistance in women with polycystic ovarian disease

Shahebrahimi, K., Rahimi, M., Salehi, N., et al. (2017) · Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Kirmānshāh · doi:10.22110/jkums.v21i1.2715

Insulin Resistance in Polycystic Ovary Syndrome Mechanism and Treatment Methods

Pei-pe, M. (2010) · Medical Recapitulate